Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease: a subpopulation analysis of phase 3 induction and maintenance studies

BACKGROUND/AIMS: Efficacy and safety of ustekinumab were evaluated in a Japanese subpopulation with moderately to severely active Crohn's disease (CD) in UNITI-1, UNITI-2 and IM-UNITI studies and results were compared with the overall population. METHODS: Overall, patients in UNITI-1 (Japan, n=...

Descripción completa

Detalles Bibliográficos
Autores principales: Hibi, Toshifumi, Imai, Yuya, Murata, Yoko, Matsushima, Nobuko, Zheng, Richuan, Gasink, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association for the Study of Intestinal Diseases 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683978/
https://www.ncbi.nlm.nih.gov/pubmed/29142515
http://dx.doi.org/10.5217/ir.2017.15.4.475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683978/
https://www.ncbi.nlm.nih.gov/pubmed/29142515
http://dx.doi.org/10.5217/ir.2017.15.4.475

Ejemplares similares